Claire Davies counsels clients on the complex and evolving legal landscape for FDA-regulated products. Using insight gained through her experience at the FDA, Claire focuses on providing practical advice to help inform clients’ business strategies and address regulatory hurdles. She has significant experience advising on a wide array of regulatory and compliance issues affecting biological products, drugs, medical devices, and human cells, tissues and cellular and tissue-based products (HCT/Ps).
